Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 2Phase 1/2 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 18Rectal Neoplasms 7Colorectal Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 4Neoplasms 3Breast Carcinoma In Situ 3Urinary Bladder Neoplasms 2Sarcoma 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Colonic Neoplasms 2Bites and Stings 2Uterine Cervical Neoplasms 1Testicular Neoplasms 1Stress, Psychological 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Seminoma 1Rhabdoid Tumor 1Retinoblastoma 1Prostatic Neoplasms 1Peritoneal Metastases From Gastric Cancer 1Peritoneal Metastases From Colorectal Cancer 1Pancreatic Neoplasms 1Osteosarcoma 1Neuroblastoma 1Neoplasm, Residual 1Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer 1Muscle Invasive Bladder Cancer 1Motor Activity 1

Interventions

Standard of Care 9Cystectomy 8Early Intervention, Educational 7Cystoscopy 6Methods 5Transurethral Resection of Bladder 4Practice Guidelines as Topic 4Multiparametric Magnetic Resonance Imaging 4Exercise 4Blood Specimen Collection 4Anesthesia, General 4Surgical Procedures, Operative 3Sevoflurane 3Radiotherapy, Intensity-Modulated 3Psychiatric Rehabilitation 3Gemcitabine 3Diet Therapy 3Cisplatin 3Anesthesia, Spinal 3Watchful Waiting 2Ultrasonography 2Therapeutics 2Surveys and Questionnaires 2Specimen Handling 2Saline Solution 2Robotic Surgical Procedures 2Radiotherapy 2Propofol 2Preoperative Exercise 2Palliative Care 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Urinary Bladder Neoplasms × Neoadjuvant Therapy × Clear all
NCT04588168 2020-10-19

Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma

The First Affiliated Hospital with Nanjing Medical University

Phase NA Recruiting
100 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00084578 2013-07-15

Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder

Fox Chase Cancer Center

Phase NA Withdrawn
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡